{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:17:58Z","timestamp":1774541878390,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jbo.2020.100301","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T10:14:11Z","timestamp":1592648051000},"page":"100301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Incidence of atypical femoral fractures in the treatment of bone metastasis: An alert report"],"prefix":"10.1016","volume":"23","author":[{"given":"Takumi","family":"Kaku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoto","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2020.100301_b0005","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.11701","article-title":"Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma","volume":"98","author":"Rosen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2020.100301_b0010","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1200\/JCO.2005.05.116","article-title":"Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial","volume":"23","author":"Kohno","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2020.100301_b0015","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1158\/1078-0432.CCR-11-3310","article-title":"Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid","volume":"18","author":"Martin","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbo.2020.100301_b0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jbo.2020.100301_b0025","first-page":"679","article-title":"Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors","volume":"22","author":"Henry","year":"2014","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jbo.2020.100301_b0030","unstructured":"Center for Cancer Control and Information Services, National Cancer Center, Cancer statistics in Japan-2018. https:\/\/ganjoho.jp\/en\/professional\/statistics\/brochure\/2018_en.html (accessed 27 February 2020)."},{"key":"10.1016\/j.jbo.2020.100301_b0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4048\/jbc.2012.15.2.261","article-title":"Atypical subtrochanteric femur fracture in patient with metastatic breast cancer treated with zoledronic acid","volume":"15","author":"Kim","year":"2012","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.jbo.2020.100301_b0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12282-011-0304-3","article-title":"A case of femoral diaphyseal fracture after long-term treatment with zoledronic acid","volume":"22","author":"Ishizuna","year":"2015","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jbo.2020.100301_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2309499017727916","article-title":"A typical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: a report of two cases","volume":"25","author":"Tateiwa","year":"2017","journal-title":"J. Orthop. Surg."},{"key":"10.1016\/j.jbo.2020.100301_b0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/RLU.0000000000002058","article-title":"Impending atypical femoral fracture in a patient of breast cancer with bone metastases receiving long-term denosumab","volume":"43","author":"Sugihara","year":"2018","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jbo.2020.100301_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2020.100301_b0060","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J. Clin. Endoclinol. Metab."},{"key":"10.1016\/j.jbo.2020.100301_b0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J. Orthop. Trauma"},{"key":"10.1016\/j.jbo.2020.100301_b0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","article-title":"Clinical correlates of atypical femoral fracture","volume":"51","author":"Lo","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100301_b0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00776-014-0572-9","article-title":"Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series","volume":"19","author":"Oh","year":"2014","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.jbo.2020.100301_b0080","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2106\/JBJS.N.00075","article-title":"Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry","volume":"96","author":"Hagen","year":"2014","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.jbo.2020.100301_b0085","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.injury.2014.08.037","article-title":"Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: mechanical analysis by the CT-based finite element method","volume":"45","author":"Oh","year":"2014","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2020.100301_b0090","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.injury.2017.09.023","article-title":"Location of atypical femoral fracture can be determined by tensile stress distribution influenced by femoral bowing and neck-shaft angle: a CT-based nonlinear finite element analysis model for the assessment of femoral shaft loading stress","volume":"48","author":"Oh","year":"2017","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2020.100301_b0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.clinbiomech.2014.08.001","article-title":"Femoral shaft strains during daily activities: implications for atypical femoral fractures","volume":"29","author":"Martelli","year":"2014","journal-title":"Clin. Biomech."},{"key":"10.1016\/j.jbo.2020.100301_b0100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bone.2018.02.015","article-title":"Influence of geometry on proximal femoral shaft strains: implications for atypical femoral fracture","volume":"110","author":"Haider","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100301_b0105","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.injury.2019.09.004","article-title":"Potential bone fragility of mid-shaft atypical femoral fracture: biomechanical analysis by a CT-based nonlinear finite element method","volume":"50","author":"Tano","year":"2019","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2020.100301_b0110","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.injury.2017.05.033","article-title":"Factors affecting fracture location in atypical femoral fractures: a cross-sectional study with 147 patients","volume":"48","author":"Kim","year":"2017","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2020.100301_b0115","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","article-title":"Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center","volume":"28","author":"Koh","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jbo.2020.100301_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00774-014-0606-6","article-title":"Atypical femoral fracture in a patient treated with denosumab","volume":"33","author":"Khow","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.jbo.2020.100301_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/17453674.2014.885355","article-title":"Atypical fracture of the femur in a patient using denosumab-a case report","volume":"85","author":"Schilcher","year":"2014","journal-title":"Acta Orthop."},{"key":"10.1016\/j.jbo.2020.100301_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2013.12.027","article-title":"Bilateral atypical femoral fractures in a patient prescribed denosumab \u2014 a case report","volume":"61","author":"Thompson","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100301_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100301_b0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1186\/s12885-019-6236-6","article-title":"Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review","volume":"19","author":"Takahashi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbo.2020.100301_b0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1634\/theoncologist.2016-0192","article-title":"Retrospective review of atypical femoral fracture in metastatic bone disease patients receiving denosumab therapy","volume":"22","author":"Yang","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.jbo.2020.100301_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2019.100259","article-title":"Atypical femoral fractures from bisphosphonate in cancer patients \u2013 review","volume":"18","author":"Lockwood","year":"2019","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.jbo.2020.100301_b0155","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00198-015-3464-8","article-title":"Hip fracture incidence in Japan: estimates of new patients in 2012 and 25-year trends","volume":"27","author":"Orimo","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.jbo.2020.100301_b0160","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jos.2017.10.008","article-title":"Treatment status and radiographic features of patients with atypical femoral fractures","volume":"23","author":"Hagino","year":"2018","journal-title":"J. Orthop. Sci."},{"key":"10.1016\/j.jbo.2020.100301_b0165","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2106\/JBJS.J.01199","article-title":"Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates","volume":"93","author":"Puhaindran","year":"2011","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.jbo.2020.100301_b0170","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jbmr.2818","article-title":"Incidence of atypical femur fractures in cancer patients: the MD Anderson Cancer Center experience","volume":"31","author":"Edwards","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbo.2020.100301_b0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17453674.2016.1277412","article-title":"Atypical femoral fractures mimicking metastatic lesions in 2 patients taking denosumab","volume":"88","author":"Austin","year":"2017","journal-title":"Acta Orthop."},{"key":"10.1016\/j.jbo.2020.100301_b0180","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s11999-012-2412-6","article-title":"Bisphosphonate-associated femur fractures have high complication rates with operative fixation","volume":"470","author":"Prasarn","year":"2012","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jbo.2020.100301_b0185","first-page":"186","article-title":"The outcome of surgically treated femur fractures associated with long-term bisphosphonate use","volume":"71","author":"Weil","year":"2011","journal-title":"J. Trauma"},{"key":"10.1016\/j.jbo.2020.100301_b0190","unstructured":"Y. Bogdan, Atypical femur fractures, in: P. Tornetta III, W.M. Ricci, R.F. Ostrum, M.M. McQueen, M.D. McKee, C.M. Court-Brown (Eds.), Rockwood and Green\u2019s fractures in adults, 9th ed., Wolters Kluwer, Alphen aan den Rijn, 2019, 2341\u20132355."},{"key":"10.1016\/j.jbo.2020.100301_b0195","doi-asserted-by":"crossref","unstructured":"B.J.X. Teo, J.S.B. Koh, S.K. Goh, M.A. Pug, D.T.C. Chua, T.S. Howe, Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy, Bone Joint J. 96-B (2014) 658\u2013664.","DOI":"10.1302\/0301-620X.96B5.32887"},{"key":"10.1016\/j.jbo.2020.100301_b0200","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.injury.2015.09.031","article-title":"High revision rate but good healing capacity of atypical femoral fractures. A comparison with common shaft fractures","volume":"46","author":"Schilcher","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.jbo.2020.100301_b0205","doi-asserted-by":"crossref","unstructured":"A. Koh, E. Guerado, P.V. Giannoudis, Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management, Bone Joint J. 99-B (2017) 295\u2013302.","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0276.R2"},{"key":"10.1016\/j.jbo.2020.100301_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115453","article-title":"Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in \u201ctypical\u201d atypical subtrochanteric femoral fracture: a proposed theory of atypical femoral fracture subtypes","volume":"137","author":"Oh","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.jbo.2020.100301_b0215","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00198-014-2738-x","article-title":"Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries","volume":"25","author":"Wang","year":"2014","journal-title":"Osteoporos. Int."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137420300567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137420300567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:17:40Z","timestamp":1761941860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137420300567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":43,"alternative-id":["S2212137420300567"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100301","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of atypical femoral fractures in the treatment of bone metastasis: An alert report","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100301"}}